Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INOTUZUMAB OZOGAMICIN Cause Blood count abnormal? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Blood count abnormal have been filed in association with INOTUZUMAB OZOGAMICIN (Besponsa). This represents 0.2% of all adverse event reports for INOTUZUMAB OZOGAMICIN.

5
Reports of Blood count abnormal with INOTUZUMAB OZOGAMICIN
0.2%
of all INOTUZUMAB OZOGAMICIN reports
1
Deaths
0
Hospitalizations

How Dangerous Is Blood count abnormal From INOTUZUMAB OZOGAMICIN?

Of the 5 reports, 1 (20.0%) resulted in death.

Is Blood count abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INOTUZUMAB OZOGAMICIN. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does INOTUZUMAB OZOGAMICIN Cause?

Death (253) Febrile neutropenia (230) Venoocclusive liver disease (229) Neoplasm progression (158) Pyrexia (151) Off label use (146) Sepsis (119) Venoocclusive disease (109) Thrombocytopenia (108) Platelet count decreased (107)

What Other Drugs Cause Blood count abnormal?

ALBUTEROL (3,248) TIOTROPIUM (1,677) PREDNISONE (1,600) BUDESONIDE\FORMOTEROL (1,595) MONTELUKAST (1,264) PALBOCICLIB (1,169) MEPOLIZUMAB (1,157) RUXOLITINIB (1,080) FLUTICASONE\SALMETEROL (841) LENALIDOMIDE (701)

Which INOTUZUMAB OZOGAMICIN Alternatives Have Lower Blood count abnormal Risk?

INOTUZUMAB OZOGAMICIN vs INSULIN INOTUZUMAB OZOGAMICIN vs INSULIN ASPART INOTUZUMAB OZOGAMICIN vs INSULIN ASPART\INSULIN DEGLUDEC INOTUZUMAB OZOGAMICIN vs INSULIN BEEF INOTUZUMAB OZOGAMICIN vs INSULIN DEGLUDEC

Related Pages

INOTUZUMAB OZOGAMICIN Full Profile All Blood count abnormal Reports All Drugs Causing Blood count abnormal INOTUZUMAB OZOGAMICIN Demographics